UniProt ID | KPCD_RAT | |
---|---|---|
UniProt AC | P09215 | |
Protein Name | Protein kinase C delta type | |
Gene Name | Prkcd | |
Organism | Rattus norvegicus (Rat). | |
Sequence Length | 673 | |
Subcellular Localization |
Cytoplasm . Nucleus . Cytoplasm, perinuclear region . Membrane Peripheral membrane protein . |
|
Protein Description | Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays contrasting roles in cell death and cell survival by functioning as a pro-apoptotic protein during DNA damage-induced apoptosis, but acting as an anti-apoptotic protein during cytokine receptor-initiated cell death, is involved in tumor suppression, is required for oxygen radical production by NADPH oxidase and acts as positive or negative regulator in platelet functional responses. Upon DNA damage, activates the promoter of the death-promoting transcription factor BCLAF1/Btf to trigger BCLAF1-mediated p53/TP53 gene transcription and apoptosis. In response to oxidative stress, interact with and activate CHUK/IKKA in the nucleus, causing the phosphorylation of p53/TP53. In the case of ER stress or DNA damage-induced apoptosis, can form a complex with the tyrosine-protein kinase ABL1 which trigger apoptosis independently of p53/TP53. In cytosol can trigger apoptosis by activating MAPK11 or MAPK14, inhibiting AKT1 and decreasing the level of X-linked inhibitor of apoptosis protein (XIAP), whereas in nucleus induces apoptosis via the activation of MAPK8 or MAPK9. Upon ionizing radiation treatment, is required for the activation of the apoptosis regulators BAX and BAK, which trigger the mitochondrial cell death pathway. Can phosphorylate MCL1 and target it for degradation which is sufficient to trigger for BAX activation and apoptosis. Is required for the control of cell cycle progression both at G1/S and G2/M phases. Mediates phorbol 12-myristate 13-acetate (PMA)-induced inhibition of cell cycle progression at G1/S phase by up-regulating the CDK inhibitor CDKN1A/p21 and inhibiting the cyclin CCNA2 promoter activity. In response to UV irradiation can phosphorylate CDK1, which is important for the G2/M DNA damage checkpoint activation. Can protect glioma cells from the apoptosis induced by TNFSF10/TRAIL, probably by inducing increased phosphorylation and subsequent activation of AKT1. Can also act as tumor suppressor upon mitogenic stimulation with PMA or TPA. In N-formyl-methionyl-leucyl-phenylalanine (fMLP)-treated cells, is required for NCF1 (p47-phox) phosphorylation and activation of NADPH oxidase activity, and regulates TNF-elicited superoxide anion production in neutrophils, by direct phosphorylation and activation of NCF1 or indirectly through MAPK1/3 (ERK1/2) signaling pathways. May also play a role in the regulation of NADPH oxidase activity in eosinophil after stimulation with IL5, leukotriene B4 or PMA. In collagen-induced platelet aggregation, acts a negative regulator of filopodia formation and actin polymerization by interacting with and negatively regulating VASP phosphorylation. Downstream of PAR1, PAR4 and CD36/GP4 receptors, regulates differentially platelet dense granule secretion; acts as a positive regulator in PAR-mediated granule secretion, whereas it negatively regulates CD36/GP4-mediated granule release. Phosphorylates MUC1 in the C-terminal and regulates the interaction between MUC1 and beta-catenin (By similarity). The catalytic subunit phosphorylates 14-3-3 proteins (YWHAB, YWHAZ and YWHAH) in a sphingosine-dependent fashion. Phosphorylates ELAVL1 in response to angiotensin-2 treatment (By similarity).; Truncated isoform 2 is inactive.. | |
Protein Sequence | MAPFLRISFNSYELGSLQAEDDASQPFCAVKMKEALTTDRGKTLVQKKPTMYPEWKSTFDAHIYEGRVIQIVLMRAAEDPMSEVTVGVSVLAERCKKNNGKAEFWLDLQPQAKVLMCVQYFLEDGDCKQSMRSEEEAMFPTMNRRGAIKQAKIHYIKNHEFIATFFGQPTFCSVCKEFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTATNSRDTIFQKERFNIDMPHRFKVYNYMSPTFCDHCGTLLWGLVKQGLKCEDCGMNVHHKCREKVANLCGINQKLLAEALNQVTQKASRKPETPETVGIYQGFEKKTAVSGNDIPDNNGTYGKIWEGSNRCRLENFTFQKVLGKGSFGKVLLAELKGKERYFAIKYLKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLICTFQTKDHLFFVMEFLNGGDLMFHIQDKGRFELYRATFYAAEIICGLQFLHGKGIIYRDLKLDNVMLDKDGHIKIADFGMCKENIFGENRASTFCGTPDYIAPEILQGLKYSFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDIMEKLFERDPAKRLGVTGNIRLHPFFKTINWNLLEKRKVEPPFKPKVKSPSDYSNFDPEFLNEKPQLSFSDKNLIDSMDQTAFKGFSFVNPKYEQFLE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
37 | Phosphorylation | VKMKEALTTDRGKTL EEHHHHHHCCCCCCH | 33.43 | 23984901 | |
38 | Phosphorylation | KMKEALTTDRGKTLV EHHHHHHCCCCCCHH | 25.25 | 23984901 | |
43 | Phosphorylation | LTTDRGKTLVQKKPT HHCCCCCCHHCCCCC | 34.68 | 23984901 | |
50 | Phosphorylation | TLVQKKPTMYPEWKS CHHCCCCCCCCCHHH | 37.91 | - | |
64 | Phosphorylation | STFDAHIYEGRVIQI HCEEEEEECCCEEEE | 11.49 | 17562707 | |
130 | Phosphorylation | EDGDCKQSMRSEEEA HCCCHHHHHCCHHHH | 11.14 | 22108457 | |
141 | Phosphorylation | EEEAMFPTMNRRGAI HHHHHCCCCCCCCHH | 18.80 | - | |
155 | Phosphorylation | IKQAKIHYIKNHEFI HHHHEEEEEECCCEE | 19.64 | 17562707 | |
164 | Phosphorylation | KNHEFIATFFGQPTF ECCCEEHHHHCCCCH | 18.06 | - | |
211 | Phosphorylation | IIGRCTGTATNSRDT HHHHCCCCCCCCCCC | 16.50 | 23984901 | |
213 | Phosphorylation | GRCTGTATNSRDTIF HHCCCCCCCCCCCCC | 33.30 | 23984901 | |
215 | Phosphorylation | CTGTATNSRDTIFQK CCCCCCCCCCCCCEE | 27.46 | 23984901 | |
218 | Phosphorylation | TATNSRDTIFQKERF CCCCCCCCCCEEHHC | 23.68 | 22673903 | |
295 | O-linked_Glycosylation | AEALNQVTQKASRKP HHHHHHHHHHHHCCC | 18.00 | 18295358 | |
295 | Phosphorylation | AEALNQVTQKASRKP HHHHHHHHHHHHCCC | 18.00 | 23984901 | |
297 | Ubiquitination | ALNQVTQKASRKPET HHHHHHHHHHCCCCC | 38.68 | - | |
299 | Phosphorylation | NQVTQKASRKPETPE HHHHHHHHCCCCCCC | 48.12 | - | |
304 | Phosphorylation | KASRKPETPETVGIY HHHCCCCCCCCCEEE | 34.65 | 28432305 | |
307 | Phosphorylation | RKPETPETVGIYQGF CCCCCCCCCEEECCC | 25.82 | 28432305 | |
311 | Phosphorylation | TPETVGIYQGFEKKT CCCCCEEECCCEECC | 9.17 | 19161989 | |
331 | Phosphorylation | DIPDNNGTYGKIWEG CCCCCCCCCCCCCCC | 31.09 | 22276854 | |
332 | Phosphorylation | IPDNNGTYGKIWEGS CCCCCCCCCCCCCCC | 20.16 | 17569658 | |
348 | O-linked_Glycosylation | RCRLENFTFQKVLGK CEEEECEEEEEECCC | 36.42 | 12639201 | |
357 | Phosphorylation | QKVLGKGSFGKVLLA EEECCCCCCHHHHHH | 34.02 | 18295358 | |
357 | O-linked_Glycosylation | QKVLGKGSFGKVLLA EEECCCCCCHHHHHH | 34.02 | 18295358 | |
372 | Phosphorylation | ELKGKERYFAIKYLK HHCCCHHEEEEEHHC | 9.84 | 10319993 | |
449 | Phosphorylation | RFELYRATFYAAEII CEEEHHHHHHHHHHH | 14.26 | - | |
504 | Phosphorylation | IFGENRASTFCGTPD CCCCCCCHHCCCCCC | 20.84 | 23991683 | |
505 | Phosphorylation | FGENRASTFCGTPDY CCCCCCHHCCCCCCC | 23.20 | 23991683 | |
509 | Phosphorylation | RASTFCGTPDYIAPE CCHHCCCCCCCCCHH | 17.73 | 27097102 | |
512 | Phosphorylation | TFCGTPDYIAPEILQ HCCCCCCCCCHHHHC | 10.53 | 27097102 | |
523 | Phosphorylation | EILQGLKYSFSVDWW HHHCCCCCEEECCHH | 21.71 | 9326592 | |
565 | Phosphorylation | IRVDTPHYPRWITKE HCCCCCCCCCCCCHH | 8.83 | 10319993 | |
592 | O-linked_Glycosylation | PAKRLGVTGNIRLHP HHHHHCCCCCEEECH | 23.78 | 182109 | |
603 | Phosphorylation | RLHPFFKTINWNLLE EECHHHCCCCHHHHH | 17.87 | 23984901 | |
628 | Phosphorylation | KVKSPSDYSNFDPEF CCCCHHHHCCCCHHH | 15.17 | 10319993 | |
629 | Phosphorylation | VKSPSDYSNFDPEFL CCCHHHHCCCCHHHH | 35.69 | 25575281 | |
643 | Phosphorylation | LNEKPQLSFSDKNLI HCCCCCCCCCCCCHH | 19.91 | 23712012 | |
645 | Phosphorylation | EKPQLSFSDKNLIDS CCCCCCCCCCCHHHH | 44.28 | 27097102 | |
652 | Phosphorylation | SDKNLIDSMDQTAFK CCCCHHHHCCHHHHC | 19.77 | 23984901 | |
656 | Phosphorylation | LIDSMDQTAFKGFSF HHHHCCHHHHCCCCC | 29.78 | 25575281 | |
662 | Phosphorylation | QTAFKGFSFVNPKYE HHHHCCCCCCCHHHH | 36.63 | 23991683 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
64 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
155 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
311 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
311 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
311 | Y | Phosphorylation | Kinase | SRC | Q9WUD9 | Uniprot |
311 | Y | Phosphorylation | Kinase | LCK | P06240 | PSP |
311 | Y | Phosphorylation | Kinase | EGFR | P00533 | PSP |
332 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
332 | Y | Phosphorylation | Kinase | EGFR | P00533 | PSP |
332 | Y | Phosphorylation | Kinase | SRC | Q9WUD9 | Uniprot |
372 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
505 | T | Phosphorylation | Kinase | PRKCE | P16054 | GPS |
505 | T | Phosphorylation | Kinase | PDPK1 | O15530 | GPS |
505 | T | Phosphorylation | Kinase | PDK1 | O55173 | GPS |
505 | T | Phosphorylation | Kinase | PRKCD | P09215 | GPS |
565 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
628 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
662 | S | Phosphorylation | Kinase | PRKCD | P09215 | GPS |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KPCD_RAT !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-MS/MS."; Moser K., White F.M.; J. Proteome Res. 5:98-104(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-662, AND MASSSPECTROMETRY. | |
"Tyrosine phosphorylation modifies protein kinase C delta-dependentphosphorylation of cardiac troponin I."; Sumandea M.P., Rybin V.O., Hinken A.C., Wang C., Kobayashi T.,Harleton E., Sievert G., Balke C.W., Feinmark S.J., Solaro R.J.,Steinberg S.F.; J. Biol. Chem. 283:22680-22689(2008). Cited for: PHOSPHORYLATION AT TYR-311; TYR-332 AND THR-505. | |
"Protein kinase Cepsilon (PKCepsilon) and Src control PKCdeltaactivation loop phosphorylation in cardiomyocytes."; Rybin V.O., Guo J., Gertsberg Z., Elouardighi H., Steinberg S.F.; J. Biol. Chem. 282:23631-23638(2007). Cited for: PHOSPHORYLATION AT THR-505. | |
"The broad specificity of dominant inhibitory protein kinase C mutantsinfers a common step in phosphorylation."; Garcia-Paramio P., Cabrerizo Y., Bornancin F., Parker P.J.; Biochem. J. 333:631-636(1998). Cited for: MUTAGENESIS OF THR-505, AND PHOSPHORYLATION AT THR-505. | |
"Induction of apoptosis is driven by nuclear retention of proteinkinase C delta."; DeVries-Seimon T.A., Ohm A.M., Humphries M.J., Reyland M.E.; J. Biol. Chem. 282:22307-22314(2007). Cited for: SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT TYR-64 AND TYR-155. |